PASG FY 2019 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena

PASGPassage Bio, Inc.

$28M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$37M

Net Income

-$46M

EPS (Diluted)

$-45.60

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$42M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$179M

Total Liabilities

$4M

Stockholders' Equity

$174M

Cash & Equivalents

$159M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$37M	-$13M	-176.2%
Net Income	-$46M	-$13M	-257.4%